GO
Loading...

Health Care Equipment

More

  • Oct 28- Edwards Lifesciences Corp on Monday reported higher-than-expected quarterly earnings, but investors were disappointed with the pace of U.S. sales of its newest artificial heart valves, sending its shares down more than 4 percent.

  • Oct 28- Edwards Lifesciences Corp on Monday reported higher-than-expected quarterly earnings as it benefited from strong sales of artificial heart valves that are implanted without major invasive surgery. Third-quarter net income rose to $77 million, or 68 cents per share, from $69 million, or 58 cents per share, a year earlier.

  • Oct 25- The U.S. Food and Drug Administration has approved Abbott Laboratories' MitraClip medical device, used to stop heart valve leakage in patients deemed unable to endure valve repair through open heart surgery, the company said on Friday. "We think longer term in the U.S., could be a $500 million product," said RBC Capital Markets analyst Glenn Novarro.

  • Abbott says FDA approved heart valve medical device Friday, 25 Oct 2013 | 9:19 AM ET

    Oct 25- Abbott Laboratories said on Friday that the U.S. Food and Drug Administration approved its MitraClip medical device, used to stop heart valve leakage. A slim majority of advisers to the FDA had recommended approval of the implantable heart device, as some had questioned whether it would be effective for its intended use.

  • WASHINGTON, Oct 24- Medical device maker Stryker Corp will pay $13.2 million to settle civil charges the company bribed doctors and government officials to win business in five different countries, U.S. regulators said Thursday.

  • Stryker to pay $13.2 mln to settle civil bribery charges Thursday, 24 Oct 2013 | 10:54 AM ET

    WASHINGTON, Oct 24- Medical device maker Stryker Corp will pay $13.2 million to settle civil charges alleging the company bribed doctors and government officials to win business in five different countries, U.S. regulators said Thursday.

  • Oct 23- Medical device maker Varian Medical Systems Inc reported lower-than-expected fourth-quarter results as demand for its products fell due to uncertainties related to U.S. healthcare reforms and reimbursement cuts. The company's fourth-quarter net earnings fell 2.4 percent to $117.3 million or $1.08 per share.

  • Proposals to toughen up European Union legislation on medical devices followed a 2011 scandal involving France's now defunct Poly Implant Prothese, which for up to a decade made substandard breast implants that were used by hundreds of thousands of women worldwide.

  • A tax on medical devices stirred the budget debate Monday, 30 Sep 2013 | 2:52 PM ET

    A detailed look at how a tax on medical devices divided so many over the White House's Affordable Care Act.

  • Why Jamie Dimon and Bill Gates have teamed up Tuesday, 24 Sep 2013 | 9:42 AM ET
    Bill Gates

    JPMorgan Chase, the Bill & Melinda Gates Foundation and others have launched an investment fund focused on late-stage healthcare technology trials.

  • Big data’s powerful effect on tiny babies Friday, 13 Sep 2013 | 5:23 PM ET
    A nurse takes care of a premature baby.

    A research project that gathers more information from hospital monitors than ever before is improving the prognosis of premature infants.

  • Forget smartwatches, consider crowdfunding this Sunday, 18 Aug 2013 | 7:00 AM ET
    Daniel Yachia, left, and Sedat Barokas

    A new Web company is offering to connect inventors of smaller medical devices with people who can give them the cash they need to get off the ground.

  • Community Health, HMA set $7.6 billion handshake Tuesday, 30 Jul 2013 | 7:16 AM ET
    An ambulance leaves Community Health's Pottstown Memorial Hospital in Pottstown, Pennsylvania, U.S.

    Community Health Systems announced it would buy Health Management Associates in a deal valued at approximately $7.6 billion, including about $3.7 billion in debt.

  • Is Intuitive Surgical's Growth Over?     Tuesday, 9 Jul 2013 | 2:11 PM ET

    Intuitive Surgical is down about 18 percent today after pre-announcing a huge miss Monday, CNBC's Herb Greenberg brings everyone up to speed; and Jason Mills, analyst at Canaccord Genuity, explains why he downgraded the stock.

  • Cramer: This Break-Up Creating Immense Value Friday, 14 Jun 2013 | 6:15 PM ET

    Jim Cramer believes this company is about to create immense value with the stroke of a pen.

  • Architect Rethinks Wheelchair Design for Stryker Tuesday, 11 Jun 2013 | 1:15 PM ET
    The "Patriot" house designed by Michael Graves.

    When architect Michael Graves realized he would spend the rest of his life in a wheelchair, he set out to improve medical design. This week Stryker unveils his wheelchair.

  • Bristol and Merck Shares Surge on Cancer Drug News Monday, 3 Jun 2013 | 3:32 PM ET

    Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.

  • Heart Device Approval Delays Leave Doctors Frustrated Monday, 27 May 2013 | 11:33 AM ET

    Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.

  • Cramer: Break-Up Could Boost This Stock 19% Friday, 17 May 2013 | 6:02 PM ET

    Cramer’s convinced the best way to for this health care company to maximize shareholder value is to break up.

  • Hospitals See Surge of Weapons in War on 'Superbugs' Monday, 29 Apr 2013 | 8:24 AM ET

    The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.

Most Popular Video

Thursday, 17 Apr 2014 | 12:09 PM ET

CNBC's Scott Cohn reports Hampshire Hotel CEO Sant Singh Chatwal pleaded guilty in a campaign scheme.

Thursday, 17 Apr 2014 | 9:14 AM ET

CNBC's David Faber speaks with Weibo chairman Charles Chao, about Weibo's growth concerns and competition in the social space.

Thursday, 17 Apr 2014 | 8:15 AM ET

Nicole Miller Regan, Piper Jaffray, shares her thoughts on Chipotle's quarterly results, and discusses her $550 price target on the stock.